【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Idiopathic Pulmonary Fibrosis Overview 9
Therapeutics Development 10
Pipeline Products for Idiopathic Pulmonary Fibrosis – Overview 10
Pipeline Products for Idiopathic Pulmonary Fibrosis – Comparative Analysis 11
Idiopathic Pulmonary Fibrosis – Therapeutics under Development by Companies 12
Idiopathic Pulmonary Fibrosis – Therapeutics under Investigation by Universities/Institutes 17
Idiopathic Pulmonary Fibrosis – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Idiopathic Pulmonary Fibrosis – Products under Development by Companies 21
Idiopathic Pulmonary Fibrosis – Products under Investigation by Universities/Institutes 25
Idiopathic Pulmonary Fibrosis – Companies Involved in Therapeutics Development 26
AdAlta Pty Ltd. 26
Aeolus Pharmaceuticals, Inc. 27
AnaptysBio, Inc. 28
Auspex Pharmaceuticals, Inc. 29
Biogen Idec Inc. 30
Bioneer Corporation 31
BiOrion Technologies B.V. 32
Boehringer Ingelheim GmbH 33
Bristol-Myers Squibb Company 34
Carolus Therapeutics, Inc. 35
Celgene Corporation 36
Chong Kun Dang Pharmaceutical Corp. 37
Compugen Ltd. 38
F. Hoffmann-La Roche Ltd. 39
FibroGen, Inc. 40
Five Prime Therapeutics, Inc. 41
GenKyoTex S.A. 42
Gilead Sciences, Inc. 43
GlaxoSmithKline plc 44
HanAll Biopharma Co., Ltd. 45
Histocell S.L. 46
iBio, Inc. 47
ImmuneWorks, LLC 48
Inventiva SAS 49
Kadmon Corporation, LLC 50
Kasiak Research Pvt. Ltd. 51
Kyorin Pharmaceutical Co., Ltd. 52
Lanthio Pharma B.V. 53
LTT Bio-Pharma Co., Ltd. 54
MedImmune, LLC 55
Moerae Matrix, Inc. 56
MSM Protein Technologies, Inc. 57
Pacific Therapeutics Ltd. 58
Pharmaxis Limited 59
Progenra, Inc. 60
Promedior, Inc. 61
ProMetic Life Sciences Inc. 62
Pulmatrix, Inc. 63
Sanofi 64
Therametrics holding AG 65
Idiopathic Pulmonary Fibrosis – Therapeutics Assessment 66
Assessment by Monotherapy Products 66
Assessment by Combination Products 67
Assessment by Target 68
Assessment by Mechanism of Action 71
Assessment by Route of Administration 73
Assessment by Molecule Type 75
Drug Profiles 77
(pentoxifylline + acetylcysteine) – Drug Profile 77
AEOL-10150 – Drug Profile 78
AM-0010 – Drug Profile 81
Antibodies to Inhibit LPA1 for Idiopathic Pulmonary Fibrosis – Drug Profile 82
Antisense RNAi Oligonucleotide for COPD and IPF – Drug Profile 83
BMS-986020 – Drug Profile 84
BOT-191 – Drug Profile 85
CC-539 – Drug Profile 86
CC-90001 – Drug Profile 87
CGEN-25009 – Drug Profile 88
CKD-942 – Drug Profile 89
CT-2009 – Drug Profile 90
FG-3019 – Drug Profile 91
FPA-008 – Drug Profile 93
GKT-137831 – Drug Profile 94
GKT-901 – Drug Profile 95
HC-016 – Drug Profile 96
HL-156FIB – Drug Profile 97
HR-017 – Drug Profile 98
IBIOCFB-03 – Drug Profile 99
ICG-001 – Drug Profile 100
interferon gamma-1b – Drug Profile 101
IVA-337 – Drug Profile 102
IW-001 – Drug Profile 103
KBP-7018 – Drug Profile 104
KD-025 – Drug Profile 105
lebrikizumab – Drug Profile 107
LP2 – Drug Profile 109
LT-0011 – Drug Profile 110
LTI-03 – Drug Profile 111
MMI-0100 – Drug Profile 112
Monoclonal Antibody for Idiopathic Pulmonary Fibrosis – Drug Profile 113
MSM-735 – Drug Profile 114
NAS-911 – Drug Profile 115
nintedanib – Drug Profile 117
omipalisib – Drug Profile 121
PBF-1250 – Drug Profile 122
PBI-4050 – Drug Profile 123
pirfenidone – Drug Profile 124
PRM-151 – Drug Profile 125
PUR-1500 – Drug Profile 127
PXS-25 – Drug Profile 128
PXS-4820 – Drug Profile 129
PXS-64 – Drug Profile 130
Refacell-IPF – Drug Profile 131
RNAi Oligonucleotides for Idiopathic Pulmonary Fibrosis – Drug Profile 132
SAR-156597 – Drug Profile 133
SD-560 – Drug Profile 134
simtuzumab – Drug Profile 135
Small Molecule 2 for Chronic Respiratory Diseases – Drug Profile 137
Small Molecules to Antagonize Integrin Alpha V for Idiopathic Pulmonary Fibrosis – Drug Profile 138
Small Molecules to Inhibit LOXL2 for Oncology and Fibrosis – Drug Profile 139
Small Molecules to Inhibit USP34 for Idiopathic Pulmonary Fibrosis – Drug Profile 140
SPL-334 – Drug Profile 141
Stem Cell Therapy for Idiopathic Lung Fibrosis – Drug Profile 142
Stem Cell Therapy for Lung Fibrosis – Drug Profile 143
STX-100 – Drug Profile 144
TD-139 – Drug Profile 145
tipelukast – Drug Profile 146
tralokinumab – Drug Profile 148
vismodegib – Drug Profile 150
ZL-2102 – Drug Profile 153
Idiopathic Pulmonary Fibrosis – Recent Pipeline Updates 154
Idiopathic Pulmonary Fibrosis – Dormant Projects 193
Idiopathic Pulmonary Fibrosis – Discontinued Products 194
Idiopathic Pulmonary Fibrosis – Product Development Milestones 195
Featured News & Press Releases 195
Appendix 203
Methodology 203
Coverage 203
Secondary Research 203
Primary Research 203
Expert Panel Validation 203
Contact Us 203
Disclaimer 204
【レポート販売概要】
■ タイトル:特発性肺線維症(Idiopathic Pulmonary Fibrosis):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015
■ 発行日:2015年3月26日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6473IDB
■ 調査対象地域:グローバル
- 3G/4Gモバイル端末の世界市場:スマートフォン、タブレット、データカードAbout 3G/4G-enabled mobile devices The global 3G/4G-enabled mobile devices market is driven by smartphones, tablets, and data cards markets. 3G/4G technology is more advanced compared to 2G. This technology allows high data uplink and downlink on 3G/4G-enabled devices. Technavio's analysts forecast the global 3G/4G-enabled mobile devices market to grow at a CAGR of 7.91% over the period 2014-2019. …
- 世界の次世代シーケンシング(NGS)市場:製品別(NOVASEQ、NEXTSEQ、SEQUEL、NANOPORE)、消耗品別、バイオインフォマティクス別、サービス別(EXOME、RNA、DENOVO)、技術別(ION、SMRT)、 用途別(診断、がん)、エンドユーザー別、地域別“The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period.” The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%. The growth of this market is largely driven by advancements in and the declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS …
- 農業用燻蒸剤の世界市場:臭化メチル、ホスフィン、クロロピクリン、メタルナトリウム、1,3-ジクロロプロペンThe global agricultural fumigants market has grown exponentially in the last few years. The market size is projected to reach USD 1.74 Billion by 2021, at a CAGR of around 4.67% from 2016 to 2021. Emerging countries such as India, Japan, France, and China are the primary targets of the industry. Increasing demand for agricultural commodities, increasing post-harvest losses, and changing farming pr …
- 医療レポート:Crohn’s Disease-疫学予測(~2022)EpiCast Report: Crohn’s Disease Epidemiology Forecast to 2022 Summary Crohn’s disease is a form of inflammatory bowel disease (IBD) characterized by recurrent inflammation of all or part of the gastrointestinal tract (CDC, 2011). Globally, the incidence rates for Crohn’s disease vary between 0.3 cases and 16.5 cases per 100,000 population, possibly indicative of an environmental influence in disea …
- 実験室用ガラス製機器/プラスチック製機器の世界市場About laboratory glassware and plasticware Laboratory glassware and plasticware include equipment, apparatus, and instruments commonly used in laboratories. These may range from microscope slides to large storage boxes and large scale condensers. Laboratory glassware is made from borosilicate glass because of its low weight and resistance to thermal shock. Laboratory plasticware, on the other hand …
- スペインの風力エネルギー分析:Analyzing Wind Energy in SpainThe wind has played a long and important role in the history of human civilization. The first known use of wind dates back 5,000 years to Egypt, where boats used sails to travel from shore to shore. The first true windmill, a machine with vanes attached to an axis to produce circular motion, may have been built as early as 2000 B.C. in ancient Babylon. By the 10th century A.D., windmills with wind …
- HEMS(ホームエネルギーマネジメントシステム)の世界市場2015-2019About HEMS A HEMS allows homeowners to monitor and reduce the energy consumption of electrical and electronic devices at home and hence to conserve energy. With HEMS, energy consumption can easily be monitored by using cellphones, tablets, or other communicating devices. It can also help in power management by tracking real-time energy consumption and comparing it with the historical data of many …
- ADMET検査(吸収/分布/代謝/排泄/毒性検査)の世界市場:インビトロADMET検査、インビボADMET検査、インシリコADMET検査ADMET Products and Services – Your Guide to Trends and Revenue Potentials The pharma ADMET testing market gains much interest from pharmaceutical companies as they look to implement more-predictive ADMET testing. That finding and many others appear in a new report by visiongain. Absorption, distribution, metabolism, excretion and toxicology (ADMET) testing is an integral part of drug development. …
- 世界のオストミーおよび尿失禁関連製品市場動向(2012-2016)TechNavio's analysts forecast the Global Ostomy and Incontinence Products market to grow at a CAGR of 5.51 percent over the period 2012-2016. The increasing elderly population is one of the key factors contributing to this market growth. The Global Ostomy and Incontinence Products market has also been witnessing an increasing demand for pull-up pants. However, advancements in surgical procedures c …
- 世界の軍事衛星市場動向2013-2023:主な開発プロジェクトThis report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Military Satellites. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
- 航空機健全性モニタリングシステム(AHMS)の世界市場:予知、診断、状態監視保全(CBM)、適応制御The aircraft health monitoring systems (AHMS) market is estimated at USD 3.43 Billion in 2016, and is projected to reach USD 4.71 Billion by 2021, at a CAGR of 6.53% from 2016 to 2021. Increase in situational awareness to drive operations, cost effective maintenance, and increase in asset utilization, and increasing volume of data generated to analyze aviation industry among others are some of the …
- K-12教育向け技術の東南アジア市場2016-2020About K-12 Education Technology The AEC was established with an aim to transform the ASEAN into a production base with a high competitive advantage and stability over the rest of the world. The community focuses on the economic, political, and socio-cultural development of its 10-member states. A major focus is on improving tertiary education and employability in the region. The conducive conditio …
- 産業用鉛蓄電池の世界市場2017-2021About Industrial Lead-acid Battery Lead-acid batteries are designed to maximize current paths and lower internal resistance. They can be serviced, are maintenance-free, and have maximum usable power. Flooded lead-acid (FLA) and valve regulated lead-acid (VRLA) batteries are the two major types of lead-acid batteries. VRLA batteries are designed to provide extended runtime without the need for high …
- The Bangchak Petroleum Public Company Limited:石油・ガスバリューチェーン分析レポート2013The Bangchak Petroleum Public Company Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "The Bangchak Petroleum Public Company Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “The Bangchak Petroleum Public Company Limited”. The report provides key information relating to oil and gas assets of th …
- セルラーM2M通信およびサービスの世界市場2016-2020About the Cellular M2M Connections and Services Market M2M technology enables the communication of data and information between electronic devices. In cellular M2M connections, code-division multiple access (CDMA), 2G, 3G, and 4G-LTE networks are used to establish connections between electronic devices. Cellular M2M has a broad range of applications in industries such as automotive, healthcare, re …